Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
September 30, 2026 99.80%
August 31, 2026 99.80%
July 31, 2026 99.80%
June 30, 2026 99.80%
May 31, 2026 99.80%
April 30, 2026 99.80%
March 31, 2026 99.80%
February 28, 2026 99.80%
January 31, 2026 99.80%
December 31, 2025 99.80%
November 30, 2025 99.80%
October 31, 2025 99.80%
September 30, 2025 99.80%
August 31, 2025 99.80%
July 31, 2025 99.80%
June 30, 2025 99.80%
May 31, 2025 99.80%
April 30, 2025 99.80%
March 31, 2025 99.80%
February 28, 2025 99.80%
January 31, 2025 99.80%
December 31, 2024 99.80%
November 30, 2024 99.80%
October 31, 2024 99.80%
September 30, 2024 99.80%
Date Value
August 31, 2024 99.80%
July 31, 2024 99.80%
June 30, 2024 99.80%
May 31, 2024 99.80%
April 30, 2024 99.80%
March 31, 2024 99.80%
February 29, 2024 99.80%
January 31, 2024 99.80%
December 31, 2023 99.80%
November 30, 2023 99.80%
October 31, 2023 99.80%
September 30, 2023 99.80%
August 31, 2023 99.80%
July 31, 2023 99.80%
June 30, 2023 99.80%
May 31, 2023 99.80%
April 30, 2023 99.80%
March 31, 2023 86.42%
February 28, 2023 76.23%
January 31, 2023 95.20%
December 31, 2022 95.20%
November 30, 2022 95.91%
October 31, 2022 95.91%
September 30, 2022 95.91%
August 31, 2022 95.91%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Proteome Sciences Plc 93.95%
Oxford BioDynamics Plc 99.88%
ICON plc 76.87%
Champions Oncology, Inc. 78.53%
Silence Therapeutics Plc 98.33%